Research article · 15 Apr 2026
Conference abstractPublished 29 Sep 2016
Radiation exposure of patient and surgeon in minimally invasive kidney stone surgery
Diskapi Yildirim Beyazit Research and Training Hospital, Turkey
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Percutaneous nephrolithotomy (PNL) and retrograde intra-renal surgery (RIRS) are the standard treatments used in the endoscopic treatment of kidney stones. The purpose of the study was to show the radiation exposure difference between the minimally invasive techniques. This is a prospective study which included 20 patients who underwent PNL, and 45 patients who underwent RIRS in our clinic between June 2014 and October 2014. The surgeries were assessed by dividing them into three steps: Step 1: The access sheath or ureter catheter placement, Step 2: Lithotripsy and collection of fragments, and Step 3: Double J catheter or re-entry tube insertion. For the PNL and RIRS groups, mean stone sizes were 30 mm (range 16-60), and 12 mm (range 7-35); mean fluoroscopy times were 337 sec. (range 200-679), and 37 sec. (range 7-351); and total radiation exposures were 142 meq (44.7 to 221), and 4.4 meq (0.2 to 30), respectively. Fluoroscopy times and radiation exposures at each step were found to be higher in the PNL group compared to the RIRS group. When assessed for the 19 PNL patients and the 12 RIRS patients who had stone sizes âÂ?¥2 cm, the fluoroscopy time in Step 1, and the radiation exposure in Steps 1 and 2 were found to be higher in the PNL group than the RIRS group (p<0.001). Although there is need for more prospective randomized studies, RIRS appears to be a viable alternate for PNL.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Aykut Demirci”
